Search
Spero Therapeutics Inc
SPROAdd to Watchlist
1.120USD
-0.050-4.27%
Close 09-10 16:00（ET）
65.42MMarket Cap
4.05P/E TTM
After-hours (ET)0.000USD0.000
After-hours (ET)Spero Therapeutics Inc (SPRO) Revenue Performance
Updated: Jun 30, 2026Last year, Spero Therapeutics Inc generated 47.03M USD for its biggest-performing segment, Collaboration Revenue Related Party. The United States made the largest contribution, accounting for 66.80M USD last year. For the latest quarter, Spero Therapeutics Inc reported the revenue of 0.00 USD for the period ending 2026-06-30, which came from the top-performing segment, Collaboration Revenue. United States contributed the highest revenue, at 0.00 USD.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
Collaboration Revenue Related Party
Collaboration Revenue
Grant Revenue
FY2025
Collaboration Revenue Related Party
47.03M(70.41%)
Collaboration Revenue
12.59M(18.84%)
Grant Revenue
7.18M(10.75%)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
FY2025
FY2024
FY2023
FY2022
FY2021
United States
66.80M(100.00%)
47.98M(100.00%)
103.78M(100.00%)
53.51M(100.00%)
18.26M(100.00%)